In this report, the Asia-Pacific Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oral Vaccines for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oral Vaccines for each application, includin
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Oral Vaccines Market Report 2017
1 Oral Vaccines Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines by Product Category
1.2.1 Asia-Pacific Oral Vaccines Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Oral Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Others
1.3 Asia-Pacific Oral Vaccines Market by Application/End Users
1.3.1 Asia-Pacific Oral Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Polio
1.3.3 Rabies
1.3.4 Rotavirus
1.3.5 Cholera
1.3.6 HIV
1.3.7 Respiratory Infections
1.3.8 Influenza
1.3.9 Tuberculosis
1.3.10 Others
1.4 Asia-Pacific Oral Vaccines Market by Region
1.4.1 Asia-Pacific Oral Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Oral Vaccines (2012-2022)
1.5.1 Asia-Pacific Oral Vaccines Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Oral Vaccines Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Oral Vaccines Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Oral Vaccines Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Oral Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Oral Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Oral Vaccines (Volume and Value) by Type
2.2.1 Asia-Pacific Oral Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Oral Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Oral Vaccines (Volume) by Application
2.4 Asia-Pacific Oral Vaccines (Volume and Value) by Region
2.4.1 Asia-Pacific Oral Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Oral Vaccines Revenue and Market Share by Region (2012-2017)

3 China Oral Vaccines (Volume, Value and Sales Price)
3.1 China Oral Vaccines Sales and Value (2012-2017)
3.1.1 China Oral Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 China Oral Vaccines Revenue and Growth Rate (2012-2017)
3.1.3 China Oral Vaccines Sales Price Trend (2012-2017)
3.2 China Oral Vaccines Sales Volume and Market Share by Type
3.3 China Oral Vaccines Sales Volume and Market Share by Application

4 Japan Oral Vaccines (Volume, Value and Sales Price)
4.1 Japan Oral Vaccines Sales and Value (2012-2017)
4.1.1 Japan Oral Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Oral Vaccines Revenue and Growth Rate (2012-2017)
4.1.3 Japan Oral Vaccines Sales Price Trend (2012-2017)
4.2 Japan Oral Vaccines Sales Volume and Market Share by Type
4.3 Japan Oral Vaccines Sales Volume and Market Share by Application

5 South Korea Oral Vaccines (Volume, Value and Sales Price)
5.1 South Korea Oral Vaccines Sales and Value (2012-2017)
5.1.1 South Korea Oral Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Oral Vaccines Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Oral Vaccines Sales Price Trend (2012-2017)
5.2 South Korea Oral Vaccines Sales Volume and Market Share by Type
5.3 South Korea Oral Vaccines Sales Volume and Market Share by Application

6 Taiwan Oral Vaccines (Volume, Value and Sales Price)
6.1 Taiwan Oral Vaccines Sales and Value (2012-2017)
6.1.1 Taiwan Oral Vaccines Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Oral Vaccines Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Oral Vaccines Sales Price Trend (2012-2017)
6.2 Taiwan Oral Vaccines Sales Volume and Market Share by Type
6.3 Taiwan Oral Vaccines Sales Volume and Market Share by Application

7 India Oral Vaccines (Volume, Value and Sales Price)
7.1 India Oral Vaccines Sales and Value (2012-2017)
7.1.1 India Oral Vaccines Sales Volume and Growth Rate (2012-2017)
7.1.2 India Oral Vaccines Revenue and Growth Rate (2012-2017)
7.1.3 India Oral Vaccines Sales Price Trend (2012-2017)
7.2 India Oral Vaccines Sales Volume and Market Share by Type
7.3 India Oral Vaccines Sales Volume and Market Share by Application

8 Southeast Asia Oral Vaccines (Volume, Value and Sales Price)
8.1 Southeast Asia Oral Vaccines Sales and Value (2012-2017)
8.1.1 Southeast Asia Oral Vaccines Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Oral Vaccines Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Oral Vaccines Sales Price Trend (2012-2017)
8.2 Southeast Asia Oral Vaccines Sales Volume and Market Share by Type
8.3 Southeast Asia Oral Vaccines Sales Volume and Market Share by Application

9 Australia Oral Vaccines (Volume, Value and Sales Price)
9.1 Australia Oral Vaccines Sales and Value (2012-2017)
9.1.1 Australia Oral Vaccines Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Oral Vaccines Revenue and Growth Rate (2012-2017)
9.1.3 Australia Oral Vaccines Sales Price Trend (2012-2017)
9.2 Australia Oral Vaccines Sales Volume and Market Share by Type
9.3 Australia Oral Vaccines Sales Volume and Market Share by Application

10 Asia-Pacific Oral Vaccines Players/Suppliers Profiles and Sales Data
10.1 GlaxoSmithKline Plc.
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Oral Vaccines Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 GlaxoSmithKline Plc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 PaxVax Corporation
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Oral Vaccines Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 PaxVax Corporation Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Pfizer Inc
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Oral Vaccines Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Pfizer Inc Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Merial, Inc.
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Oral Vaccines Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Merial, Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Merck Sharp & Dohme Corp
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Oral Vaccines Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Merck Sharp & Dohme Corp Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 VALNEVA Canada Inc.
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Oral Vaccines Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 VALNEVA Canada Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 QUíMICA SUIZA S.A
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Oral Vaccines Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 QUíMICA SUIZA S.A Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Immunitor, Inc
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Oral Vaccines Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Immunitor, Inc Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Aventis (Sanofi S.A.)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Oral Vaccines Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Aventis (Sanofi S.A.) Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Serum Institute of India Pvt. Ltd
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Oral Vaccines Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Serum Institute of India Pvt. Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Swiss Serum and Vaccine Institute Berne
10.12 Bull Bio - NCIPD Ltd.
10.13 Vaxart, Inc.
10.14 Shantha Biotechnics
10.15 Crucell (Janssen Global Services, LLC)

11 Oral Vaccines Manufacturing Cost Analysis
11.1 Oral Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oral Vaccines

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Oral Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Oral Vaccines Market Forecast (2017-2022)
15.1 Asia-Pacific Oral Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Oral Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Oral Vaccines Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Oral Vaccines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Oral Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Oral Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Oral Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Oral Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Oral Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Oral Vaccines Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Oral Vaccines Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Oral Vaccines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Oral Vaccines Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer




List of Tables and Figures

Figure Product Picture of Oral Vaccines
Figure Asia-Pacific Oral Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Oral Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Attenuated Vaccines Product Picture
Figure Killed/Inactivated Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure Others Product Picture
Figure Asia-Pacific Oral Vaccines Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Oral Vaccines by Application in 2016
Figure Polio Examples
Table Key Downstream Customer in Polio
Figure Rabies Examples
Table Key Downstream Customer in Rabies
Figure Rotavirus Examples
Table Key Downstream Customer in Rotavirus
Figure Cholera Examples
Table Key Downstream Customer in Cholera
Figure HIV Examples
Table Key Downstream Customer in HIV
Figure Respiratory Infections Examples
Table Key Downstream Customer in Respiratory Infections
Figure Influenza Examples
Table Key Downstream Customer in Influenza
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Oral Vaccines Market Size (Million USD) by Region (2012-2022)
Figure China Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Vaccines Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Vaccines Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Oral Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Oral Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oral Vaccines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Oral Vaccines Sales Share by Players/Suppliers
Figure Asia-Pacific Oral Vaccines Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Oral Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Oral Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oral Vaccines Revenue Share by Players
Figure 2017 Asia-Pacific Oral Vaccines Revenue Share by Players
Table Asia-Pacific Oral Vaccines Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Oral Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Vaccines by Type (2012-2017)
Figure Asia-Pacific Oral Vaccines Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Oral Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Oral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type (2012-2017)
Figure Asia-Pacific Oral Vaccines Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Oral Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Oral Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Vaccines by Region (2012-2017)
Figure Asia-Pacific Oral Vaccines Sales Market Share by Region in 2016
Table Asia-Pacific Oral Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Oral Vaccines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Region (2012-2017)
Figure Asia-Pacific Oral Vaccines Revenue Market Share by Region in 2016
Table Asia-Pacific Oral Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Oral Vaccines Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Oral Vaccines Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Oral Vaccines Sales Market Share by Application (2012-2017)
Figure China Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure China Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table China Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table China Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure China Oral Vaccines Sales Volume Market Share by Type in 2016
Table China Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table China Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure China Oral Vaccines Sales Volume Market Share by Application in 2016
Figure Japan Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Japan Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Japan Oral Vaccines Sales Volume Market Share by Type in 2016
Table Japan Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Japan Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Japan Oral Vaccines Sales Volume Market Share by Application in 2016
Figure South Korea Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table South Korea Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure South Korea Oral Vaccines Sales Volume Market Share by Type in 2016
Table South Korea Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure South Korea Oral Vaccines Sales Volume Market Share by Application in 2016
Figure Taiwan Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Oral Vaccines Sales Volume Market Share by Type in 2016
Table Taiwan Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Oral Vaccines Sales Volume Market Share by Application in 2016
Figure India Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure India Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table India Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table India Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure India Oral Vaccines Sales Volume Market Share by Type in 2016
Table India Oral Vaccines Sales Volume (K Units) by Application (2012-2017)
Table India Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure India Oral Vaccines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oral Vaccines Sales Volume Market Share by Type in 2016
Table Southeast Asia Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oral Vaccines Sales Volume Market Share by Application in 2016
Figure Australia Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Oral Vaccines Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Oral Vaccines Sales Volume (K Units) by Type (2012-2017)
Table Australia Oral Vaccines Sales Volume Market Share by Type (2012-2017)
Figure Australia Oral Vaccines Sales Volume Market Share by Type in 2016
Table Australia Oral Vaccines Sales Volume (K Units) by Applications (2012-2017)
Table Australia Oral Vaccines Sales Volume Market Share by Application (2012-2017)
Figure Australia Oral Vaccines Sales Volume Market Share by Application in 2016
Table GlaxoSmithKline Plc. Oral Vaccines Basic Information List
Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table PaxVax Corporation Oral Vaccines Basic Information List
Table PaxVax Corporation Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure PaxVax Corporation Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc Oral Vaccines Basic Information List
Table Pfizer Inc Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Merial, Inc. Oral Vaccines Basic Information List
Table Merial, Inc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Merial, Inc. Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Sharp & Dohme Corp Oral Vaccines Basic Information List
Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table VALNEVA Canada Inc. Oral Vaccines Basic Information List
Table VALNEVA Canada Inc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table QUíMICA SUIZA S.A Oral Vaccines Basic Information List
Table QUíMICA SUIZA S.A Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Immunitor, Inc Oral Vaccines Basic Information List
Table Immunitor, Inc Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Immunitor, Inc Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Aventis (Sanofi S.A.) Oral Vaccines Basic Information List
Table Aventis (Sanofi S.A.) Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Serum Institute of India Pvt. Ltd Oral Vaccines Basic Information List
Table Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Market Share in Asia-Pacific (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Revenue Market Share in Asia-Pacific (2012-2017)
Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Basic Information List
Table Bull Bio - NCIPD Ltd. Oral Vaccines Basic Information List
Table Vaxart, Inc. Oral Vaccines Basic Information List
Table Shantha Biotechnics Oral Vaccines Basic Information List
Table Crucell (Janssen Global Services, LLC) Oral Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure Asia-Pacific Oral Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oral Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Oral Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Vaccines Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Vaccines Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Oral Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Vaccines Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Vaccines Revenue Market Share Forecast by Region in 2022
Figure China Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Oral Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Oral Vaccines Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oral Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Oral Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oral Vaccines Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Oral Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Oral Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Vaccines Isothermal Boxes Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Vaccines Isothermal Boxes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...

Global Sleep Apnea Oral Appliances Market Report- Global Strategic Analysis, Size, Share, Trend, and Forecast (2023-2030)...

This report gives an insight into the global Sleep Apnea Oral Appliances Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall ...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

Global Potassium Chloride Oral Solution Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Potassium Chloride Oral Solution Market: The report discusses everything a marketer requires before investing in the global Potassium Chloride Oral Solution Market during the forecast period 2...

2023-2028 Global and Regional Liquid Paraffin Oral Emulsion Industry Status and Prospects Professional Market Research Report Standard Version...

The global Liquid Paraffin Oral Emulsion market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...

2023-2028 Global and Regional Oral hypoglycemic agents and insulin analogues Industry Status and Prospects Professional Market Research Report Standard Version...

The global Oral hypoglycemic agents and insulin analogues market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will h...

2023-2028 Global and Regional Human Rabies Vaccines Industry Status and Prospects Professional Market Research Report Standard Version...

The global Human Rabies Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...